# Avera Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/avera-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: San Diego, US
- Total disclosed funding: $72M
- Latest round: Series C (Jan 2, 2007)
- Investors on record: 12

## About

Founded in 2002, Avera Pharmaceuticals is a pharmaceutical company engages in the development and commercialization of pharmaceutical compounds. It offers drug candidates to treat unmet medical needs, such as neurovisceral disorders.

## Funding rounds

- Series C, Jan 2, 2007, $0.4M — Montreux Equity Partners
- Series C, Aug 4, 2004, $48M — Frazier Healthcare Partners, InterWest Partners, Perseus, Aberdare Ventures, Montreux Equity Partners, St. Paul Venture Capital, BioAsia Investments, SV Health Investors, H.I.G. BioHealth Partners, Windamere Venture Partners, Bay City Capital, BTG
- Series B, Nov 10, 2003, $8M — Frazier Healthcare Partners, InterWest Partners, St. Paul Venture Capital, Windamere Venture Partners, Bay City Capital, BTG
- Series A, May 27, 2002, $16M — Frazier Healthcare Partners, Windamere Venture Partners, Bay City Capital

## Investors

- Frazier Healthcare Partners (https://capitalatlas.ai/funds/frazier-healthcare-partners) — Series A, Series B, Series C
- Windamere Venture Partners (https://capitalatlas.ai/funds/windamere-venture-partners) — Series A, Series B, Series C
- Bay City Capital (https://capitalatlas.ai/funds/bay-city-capital) — Series A, Series B, Series C
- InterWest Partners (https://capitalatlas.ai/funds/interwest-partners) — Series B, Series C
- St. Paul Venture Capital (https://capitalatlas.ai/funds/st-paul-venture-capital) — Series B, Series C
- BTG — Series B, Series C
- Perseus (https://capitalatlas.ai/funds/perseus) — Series C
- Aberdare Ventures (https://capitalatlas.ai/funds/aberdare-ventures) — Series C
- Montreux Equity Partners (https://capitalatlas.ai/funds/montreux-equity-partners) — Series C
- BioAsia Investments (https://capitalatlas.ai/funds/bioasia-investments) — Series C
- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Series C
- H.I.G. BioHealth Partners (https://capitalatlas.ai/funds/h-i-g-biohealth-partners) — Series C